SLC16A2 and Allan-Herndon-Dudley syndrome: Assuming that the T3 release of the thyroid is not harmed in MCT8-deficiency (which could be explained by further membrane transporters) (8), the serum FT3 concentrations of AHDS patients would be higher compared to healthy individuals.